SHANGHAI, May 26, 2021 /PRNewswire/ -- Luye Pharma Group announced today that its holding subsidiar...
MIESBACH, Germany and BASEL, Switzerland, May 24, 2021 /PRNewswire/ -- Luye Pharma Group today anno...
BOSTON, May 13, 2021 /PRNewswire/ -- The Boston R&D Center and GeneLeap Biotech, two subsidiaries o...
BOSTON, April 14, 2021 /PRNewswire/ -- GeneLeap Bio., a subsidiary of Luye Life Sciences specializi...
BASEL, Switzerland, Feb. 18, 2021 /PRNewswire/ -- Luye Pharma Group announced that its subsidiary L...
* Luye Pharma grants Distriphil exclusive distribution and marketing rights for Seroquel® and Ser...
SHANGHAI, Oct. 19, 2020 /PRNewswire/ -- The Second Asia Pacific Psychiatry Symposium hosted by Luye...
SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing...
MISBACH, Germany, May 20, 2020 /PRNewswire/ -- Luye Pharma Group announced today that the Marketing...
SHANGHAI, March 27, 2020 /PRNewswire/ -- Luye Pharma Group (02186.HK) reported its financial result...
SHANGHAI, March. 4, 2020 /PRNewswire/ -- Luye Pharma Group has announced that the U.S. Food and Dru...
HONG KONG, Feb. 10, 2020 /PRNewswire/ -- Luye Pharma Group has announced that it has entered into a...
SHANGHAI, Nov. 4, 2019 /PRNewswire/ -- LY03004, Luye Pharma's innovative, independently developed E...
SHANGHAI, Sept. 3, 2019 The first-ever Asia Pacific Psychiatric Conference hosted by the Luye Pharm...
NANJING, China, Sept. 3, 2019 /PRNewswire/ -- The first-ever Asia Pacific Psychiatric Conference ho...
SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- Luye Pharma Group (02186.HK) released its financial results...
TOKYO, Aug. 22, 2019 /PRNewswire/ -- Luye Pharma Group has announced its submission of the clinical...
SHANGHAI, May 30, 2019 /PRNewswire/ -- Rykindo® (LY03004), Luye Pharma's innovative, independently ...